SoftwareCPR®, experts in FDA and standards compliance, have an extensive network of industry-leading affiliates that work on our larger projects and/or provide special expertise.
Annette has been a regulatory affairs consultant since 1998. Prior to consulting, she was Director, Regulatory Affairs, for Critikon, a Johnson & Johnson Company, where she worked with cardiovascular monitoring devices. She has over 25 years experience in regulatory affairs, compliance and clinical affairs with prior experiences in the implantable cardiovascular and ophthalmic devices industries. Her worldwide regulatory affairs responsibilities have included FDA submissions, GMP/QS compliance, interpretation of all FDA regulations and policies, regulatory representation on new product development teams, product liability and international product registrations. She has also represented Johnson & Johnson on several software related FDA/industry guidance and standards-setting activities.
Annette is Regulatory Affairs Certified and holds BA degrees in biology, microbiology and secondary science education.
Led the first AI-enabled De Novo approval of SaMD. Former Chief Quality and Regulatory Officer, Management Representative under ISO 13485, Person Responsible for Regulatory Compliance under EU MDR, Lead auditor for ISO 13485 (MDR, MHLW Ordinance No. 169), and supports Mass Gen Digital CRO strategy and planning related to FDA submissions. Senior expert with pre-subs, De Novo and 510(k) submissions, strategy, FDA negotiation and interaction.
Karen is an extremely talented regulatory affairs consultant and university assistant professor. Her expertise covers US, Canada, European, and global regulatory regulations. In addition to her teaching role, she has worked in medical device companies driving regulatory and quality management systems. She is trained in auditing across the quality management systems.
Karen holds her Juris Doctor from the University of Maryland School of Law as well as undergraduate and graduate science degrees.
Robert is a former Principal Scientist with GE Healthcare and has 40+ years’ experience in medical device software and systems development. He as designed and implemented ECG, blood pressure, and other signal processing systems in research and product development settings. He has a long track record of understanding quality assurance, both from a compliance perspective but also from success at delivery production-ready, robust medical devices used globally. Robert is a member of the AAMI Sphygmomanometer Committee, AAMI ECG/Arrhythmia Monitoring Working Group, and AAMI ECG/Ambulatory Electrocardiograph Working Group.
Expertise includes organizational development, culture assessment, change management, people assessment and coaching.
IEC 62304 and other emerging standards for Medical Device and HealthIT Software
Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future. Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply. Special deep discount pricing available to FDA attendees and other regulators.
3-days with group exercises, quizzes, examples, Q&A.
Instructor: Brian Pate
Next public offering: June 24-26, 2025 (Virtual, Live)
For private, in-house courses, please contact us.
Email training@softwarecpr.com for more info.
Being Agile & Yet Compliant (Public)
Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for registration!
3 days virtual (Zoom) with group exercises, quizzes, examples, Q&A.
Lead Instructor: Mike Russell
Next public offerings:
Medical Device Cybersecurity (Public or Private)
This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.
2-days onsite with group exercises, quizzes, examples, Q&A.
Instructor: Dr Peter Rech, 2nd instructor (optional)
Next public offering: TBD